Published in Anesthesiology on December 01, 1981
Reducing the oxygen concentration of gases delivered from anaesthetic machines unadapted for medical air. Vet Rec (2011) 1.40
Health hazards and nitrous oxide: a time for reappraisal. Anesth Prog (1992) 0.95
Nitrous oxide anesthesia and plasma homocysteine in adolescents. Anesth Analg (2011) 0.86
Pre-operative vitamin B infusion and prevention of nitrous oxide-induced homocysteine increase. Anaesthesia (2010) 0.78
Nitrous oxide and perioperative outcomes. J Anesth (2013) 0.76
The hematological effects of nitrous oxide anesthesia in pediatric patients. Anesth Analg (2015) 0.76
Bibliography for the control of anxiety, fear and pain in dentistry. Anesth Prog (1983) 0.75
Megaloblastic hematopoiesis in a 20 year old pregnant female. Am J Case Rep (2013) 0.75
Myb-related Schizosaccharomyces pombe cdc5p is structurally and functionally conserved in eukaryotes. Mol Cell Biol (1998) 10.34
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension (1999) 3.33
Translocation as a species conservation tool: status and strategy. Science (1989) 3.31
Localization and conditional redundancy of regulatory elements in rbcS-3A, a pea gene encoding the small subunit of ribulose-bisphosphate carboxylase. Proc Natl Acad Sci U S A (1988) 3.23
Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell (1992) 3.20
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry (2001) 3.18
Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men. Am J Clin Nutr (1976) 3.17
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet (2000) 2.82
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet (1992) 2.63
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40
Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet (1997) 2.39
Indicators of effective cytological sampling of the uterine cervix. Lancet (1989) 2.39
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut (2003) 2.06
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
DNA homology between a novel human herpesvirus (HHV-6) and human cytomegalovirus. Lancet (1988) 1.94
Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87
Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping. Am J Hum Genet (1993) 1.83
Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev (2007) 1.71
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol (1988) 1.66
Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology (1996) 1.66
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Ann Intern Med (1999) 1.65
Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63
Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax (2009) 1.62
Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS (2001) 1.61
Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med (2000) 1.61
Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. Semin Hematol (2000) 1.59
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant (2008) 1.56
Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet (1997) 1.55
Estimation of body fatness by air displacement plethysmography in African American and white children. Pediatr Res (2001) 1.55
Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol (1997) 1.53
Localisation of the vaso-motor centre. J Physiol (1923) 1.51
A randomized control trial of two cervical spatulas. Br J Obstet Gynaecol (1991) 1.50
Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation (2000) 1.48
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology (2000) 1.47
Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest (2000) 1.46
The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant (1999) 1.43
The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant (2004) 1.40
Late effects of transplantation. Gerard Socie, for the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Lancet (1999) 1.39
In vitro studies of suppressor cell function in human peripheral blood mononuclear cells. Clin Exp Immunol (1978) 1.39
Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology (1997) 1.38
Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38
Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37
The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34
Absence of oats toxicity in adult coeliac disease. BMJ (1996) 1.34
Organelle-cytoskeletal interactions: actin mutations inhibit meiosis-dependent mitochondrial rearrangement in the budding yeast Saccharomyces cerevisiae. Mol Biol Cell (1995) 1.33
Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 1.29
Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta (1998) 1.29
Coeliac disease during the teenage period: the value of serial serum folate estimations. Gut (1974) 1.26
Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25
The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant (2005) 1.25
Mutations of the 22- and 27-kD zein promoters affect transactivation by the Opaque-2 protein. Plant Cell (1992) 1.21
Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21
Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM (1997) 1.21
A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet (1993) 1.21